APLS ; target $40 pushed by 17% short interest
Short interest of 17% can push this out of the wedge formed. Pharma stocks will make a comeback closer we get to vaccine hypes again once the tech bubble pops
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.